© Globe Newswire
12.03.2025
AGFB
LISTED
EURONEXT
The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets - regulated information
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.03.2025
ZEAL
LISTED
CPH
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
News Preview
Company announcement – No. 4 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
11.03.2025
TEM
LISTED
NASDAQ
Tempus Announces Acquisition of Deep 6 AI
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies.
Deep 6 AI enables healthcare organizations to de-risk clinical trials,...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
11.03.2025
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit’s dedication to providing high-quality, evidence-based care t...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
11.03.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer
News Preview
OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
HNSA
LISTED
STO
Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients
News Preview
LUND, Sweden, March 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, 'Hansa' (Nasdaq Stockholm: HNSA), announced today that it has completed enrolment of its 20-HMedIdeS-19 Post Authorization Efficacy and Safety (PAES) study, an open-label Phase 3 confirmatory study in Europe investigating the one-year patient and graft survival in highly sensitized...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
HNSA
LISTED
STO
Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients
News Preview
LUND, Sweden, March 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, 'Hansa' (Nasdaq Stockholm: HNSA), announced today that it has completed enrolment of its 20-HMedIdeS-19 Post Authorization Efficacy and Safety (PAES) study, an open-label Phase 3 confirmatory study in Europe investigating the one-year patient and graft survival in highly sensitized...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
SN
LISTED
LSE
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:...
Themefolio
Profiler
Peergroup
© PR Newswire
11.03.2025
ATNM
LISTED
XASE
Actinium Pharmaceuticals Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly Diagnosed AML
News Preview
Represents first ever triplet combination using targeted radiotherapy as a backbone therapy in AML with initial clinical data expected in 2H:2025Expansion into frontline setting greatly expands potential addressable patient opportunity for Actimab-ATriplet combination supported by previously completed Phase 1 trials of Actimab-A + Venetoclax and...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
LEGN
LISTED
NASDAQ
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
News Preview
SOMERSET, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported financial results for the fourth quarter and year ended December 31, 2024, and key corporate highlights....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ATAI
LISTED
NASDAQ
atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
News Preview
- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering from treatment-resistant depression...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Group Financial Statement documents 2024 and Remuneration Report published
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT11 MARCH 2025 at 11.15 EET ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Outi Vaarala
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Liisa Hurme
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Olli Huotari
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Julia Macharey
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Hao Pan
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Niclas Lindstedt
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Satu Ahomäki
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – René Lindell
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MARCH 2025 at 09.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
GNFT
LISTED
EURONEXT
Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), March 10, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases (the “Company”), today announces the results of the bondholders’ vote at the general meeting of th...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
AMRX
LISTED
NASDAQ
Amneal to Participate at Upcoming Investor Conference
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will present at the Barclays 27th Annual Global Healthcare Conference on March, 12, 2025. Chirag Patel, Co-Chief Executive Officer and President, will participate in a fireside chat at 11:00 AM ET. A live webcast of the fireside chat will be accessible on the Company's website at https://investors.amneal...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
IMCR
LISTED
NASDAQ
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
News Preview
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES10 MARCH 2025 at 19.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS10 March 2025 at 17.00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
SN
LISTED
LSE
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
GMAB
LISTED
CPH
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
SLP
LISTED
NASDAQ
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in a fireside chat at the KeyBan...
Themefolio
Profiler
Peergroup
© ActuNews
06.03.2025
ALTHX
LISTED
EURONEXT
THERANEXUS : MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
News Preview
Lyon, France – 6 mars 2025, 18h00 CET – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, annonce aujourd'hui une modification de son contrat de liquidité confié à Portzamparc par suite des évolutions de la règlementation affér...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Hosts KOL Webinar Post-ECCO on Lusvertikimab and the Future of IBD
News Preview
OSE Immunotherapeutics Hosts KOL Webinar Post-ECCO on Lusvertikimab and the Future of IBD...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
SN
LISTED
LSE
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) highlights the exceptional performance of Smith+Nephew’s proprietary OXINIUM on highly cross-linked polyethylene. The data indicates th...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© BusinessWire
06.03.2025
DFTX
LISTED
NASDAQ
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its fourth quarter and full year 2024 financial results and provided an update on business highlights.
“2024 was a year of significant progr...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
News Preview
MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Mark...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
News Preview
Autolus will report Q4 and FY 2024 financial results and operational updates on March 20, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
SECT_B
LISTED
STO
Top-rated US health system expands Sectra's enterprise imaging solution with digital pathology to enhance collaboration for improved cancer care
News Preview
LINKÖPING, Sweden, March 6, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that a US health system will expand its use of Sectra's enterprise imaging solution with digital pathology. The digital solution will enhance diagnostic speed by enabling pathologists to review and collaborate...
Themefolio
Profiler
Peergroup
© Newsfile
06.03.2025
COPN
LISTED
SIX
Cosmo Pharmaceuticals Delivers Record 2024 Results - Completes Phase III Enrollment for Androgenetic Alopecia in Males - Proposes Increased Dividend of 2.05 per share - Reinforcing Shareholder Value and Growth Momentum into 2025
News Preview
Ad hoc announcement pursuant to Art. 53 LR FY 2024 Revenue of €266.8 million (unaudited) reaching upper end of guidance FY 2024 Operating Profit (unaudited) of €148.9 million, exceeding guidance, when adjusted for an accounting policy change Outlook for 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
FAGR
LISTED
EURONEXT
Fagron publishes its annual report 2024
News Preview
Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2025 – 7AM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
EHAB
LISTED
NYSE
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024.
“Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments,” said Barb Jacobsmeyer, president and chief...
Themefolio
Profiler
Peergroup
© PR Newswire
05.03.2025
VITR
LISTED
STO
In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement
News Preview
GOTHENBURG, Sweden, March 5, 2025 /PRNewswire/ -- Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no formal complaint has been served yet. During the fourth quarter of 2024, similar class actions we...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS5 March 2025 at 17.00 EET ...
Themefolio
Profiler
Peergroup
© PR Newswire
05.03.2025
CU6
LISTED
ASX
SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.
News Preview
HIGHLIGHTS
Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study.Based on the efficacy and safety assessment of all cohorts and the focus on earlier stages of treatment, the SRC confirmed expansion at 8 GBq dose level and recommended to i...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at Upcoming Investor Conferences
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025 at 8.00 am ET and at the Barclays 27th Annual Global Healthcare Conference on Thursday, Ma...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
ORY
LISTED
BME
Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat
News Preview
MADRID and CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the final results of an observational clinical study aimed at psychometrically...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
NSIS B
LISTED
CPH
Initiation of share buyback program
News Preview
On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million in total during the remainder of 2025, corresponding to around 1.7 million B shares at the current share price. The program is contingent u...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
News Preview
COPENHAGEN, Denmark, March 5, 2025 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
ORNBV
LISTED
HEL
Orion and Aiforia extend collaboration to preclinical study evaluations
News Preview
ORION CORPORATION PRESS RELEASE 5 MARCH 2025 at 9.00 EET...
Themefolio
Profiler
Peergroup
© PR Newswire
04.03.2025
CYRX
LISTED
NASDAQ
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
FY 2024 revenue of $228.4 million, in-line with company guidanceCommercial Cell & Gene Therapy revenue rose to $26 million in FY 2024, up 20% year-over-year Supporting a record total of 701 global clinical trials as of December 31, 2024NASHVILLE, Tenn., March 4, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in...
Themefolio
Profiler
Peergroup
© ActuNews
04.03.2025
OXUR
LISTED
EURONEXT
Oxurion verlengt haar financieringsprogramma
News Preview
LEUVEN, BELGIË - 04 maart 2025 – 19u00 CET - Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch bedrijf met hoofdzetel in Leuven, kondigt de ondertekening aan van een derde amendement op haar converteerbare obligatie-intekeningsovereenkomst met Atlas Special Opportunities, LLC. Als onderdeel van deze wijziging is de overeenkomst...
Themefolio
Profiler
Peergroup
© ActuNews
04.03.2025
OXUR
LISTED
EURONEXT
Oxurion Extends Its Financing Program
News Preview
LEUVEN, BELGIUM – March 4, 2025 – 07:00PM – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a third amendment to its convertible bond subscription agreement with Atlas Special Opportunities, LLC. As part of this amendment, the agreement has been assigned to Atlas...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.03.2025
GMAB
LISTED
CPH
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
04.03.2025
INDV
LISTED
NASDAQ
Indivior Announces Further Changes to Board of Directors
News Preview
RICHMOND, Va., March 4, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ / LSE: INDV) ("Indivior" or the "Company") today announced that, further to the announcement on December 17, 2024 of certain Director arrangements agreed with Oaktree Capital Management L.P. ("Oaktree"), the announcement on January 28, 2025 of the appointment of Dr. David Wheadon a...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
DFTX
LISTED
NASDAQ
MindMed to Present at Leerink’s Global Healthcare Conference 2025
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will present at Leerink’s Global Healthcare Conference:
Leerink’s Global Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.03.2025
TIL
LISTED
NASDAQ
Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
News Preview
Clinical data for AXN-2510/IMM2510 monotherapy in relapsed/refractory NSCLC in China by ImmuneOnco, as well as additional safety data in other solid tumors, anticipated in 1H 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
04.03.2025
RAY B
LISTED
STO
The Chinese carbon ion center Heyou Hospital selects RayStation
News Preview
STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City, Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 million (approximately SEK 77 million), of which RMB 1...
Themefolio
Profiler
Peergroup
© PR Newswire
04.03.2025
RAY B
LISTED
STO
The Chinese carbon ion center Heyou Hospital selects RayStation
News Preview
STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City, Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 million (approximately SEK 77 million), of which RMB 1...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
